TCG Crossover Management, LLC

Position in LQDA — Liquidia Corp

CIK 1839948 PALO ALTO, CA

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,211,031

-$43,769,766 QoQ

Shares Held

403,048

-76.4% QoQ

Ownership

0.453%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

TCG Crossover Management, LLC holds $249,632,788 across 4 Drug Manufacturers - Specialty & Generic names. LQDA ranks #4 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	11,020,968	$104,919,615
2	AMLX	Amylyx Pharmaceuticals, Inc.	6,243,812	$86,788,986
3	ADCT	ADC Therapeutics SA	11,390,175	$42,713,156
4	LQDA	Liquidia Corp This page	403,048	$15,211,031

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,211,031	403,048	-76.4%	Shares	Sole	2026-05-15
2025-12-31	$58,980,797	1,710,084	0.0%	Shares	Sole	2026-02-17
2025-09-30	$38,887,310	1,710,084	—	Shares	Sole	2025-11-17
No filing history on record for this holder in this stock.